BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30385998)

  • 1. Giant Cell Arteritis: 2018 Review.
    Winkler A; True D
    Mo Med; 2018; 115(5):468-470. PubMed ID: 30385998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of tocilizumab in refractory giant cell arteritis.
    Vinit J; Bielefeld P; Muller G; Besancenot JF
    Joint Bone Spine; 2012 May; 79(3):317-8. PubMed ID: 22284606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab in the treatment of giant cell arteritis.
    Leuchten N; Aringer M
    Immunotherapy; 2018 Mar; 10(6):465-472. PubMed ID: 29504436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is visual loss due to giant cell arteritis reversible?
    Calgüneri M; Cobankara V; Ozatli D; Güler G; Apraş S; Pay S; Kiraz S; Ertenli I; Oztürk MA
    Yonsei Med J; 2003 Feb; 44(1):155-8. PubMed ID: 12619191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive treatment for giant cell arteritis: where do we stand?
    Pipitone N; Salvarani C
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-5-6. PubMed ID: 26016749
    [No Abstract]   [Full Text] [Related]  

  • 6. Polymyalgia Rheumatica and Giant Cell Arteritis.
    Buttgereit F; Matteson EL; Dejaco C
    JAMA; 2020 Sep; 324(10):993-994. PubMed ID: 32897333
    [No Abstract]   [Full Text] [Related]  

  • 7. Tocilizumab for giant cell arteritis: an amazing result.
    Işık M; Kılıç L; Doğan İ; Calgüneri M
    Rheumatol Int; 2013 Nov; 33(11):2961-2. PubMed ID: 22965672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Large-vessel vasculitis-giant cell and Takayasu arteritis].
    Villiger PM
    Internist (Berl); 2019 Oct; 60(10):1059-1073. PubMed ID: 31471629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients.
    Régent A; Redeker S; Deroux A; Kieffer P; Ly KH; Dougados M; Liozon E; Larroche C; Guillevin L; Bouillet L; Espitia O; Costedoat-Chalumeau N; Soubrier M; Brihaye B; Lifermann F; Lefevre G; Puéchal X; Mouthon L; Toussirot E;
    J Rheumatol; 2016 Aug; 43(8):1547-52. PubMed ID: 27182063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of scalp necrosis.
    Griffin L; Hackett C; Ryan S; Leonard N; Ramsay B
    Clin Exp Dermatol; 2019 Jan; 44(1):106-109. PubMed ID: 29952020
    [No Abstract]   [Full Text] [Related]  

  • 11. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
    Monti S; Águeda AF; Luqmani RA; Buttgereit F; Cid M; Dejaco C; Mahr A; Ponte C; Salvarani C; Schmidt W; Hellmich B
    RMD Open; 2019; 5(2):e001003. PubMed ID: 31673411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tongue necrosis secondary to giant cell arteritis, successfully treated with tocilizumab: a case report.
    Cho YM; El Khoury L; Paramo J; Horowitz DM; Li JY; Kello N
    BMC Musculoskelet Disord; 2023 May; 24(1):382. PubMed ID: 37189114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).
    Spiera RF; Mitnick HJ; Kupersmith M; Richmond M; Spiera H; Peterson MG; Paget SA
    Clin Exp Rheumatol; 2001; 19(5):495-501. PubMed ID: 11579707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of giant cell arteritis].
    Samson M; Greigert H; Ghesquière T; Bonnotte B
    Presse Med; 2019 Sep; 48(9):968-979. PubMed ID: 31324351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and emerging diagnosis tools and therapeutics for giant cell arteritis.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Rev Clin Immunol; 2018 Jul; 14(7):593-605. PubMed ID: 29877748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of giant cell arteritis: what is in the pipeline?].
    Holle JU; Moosig F
    Z Rheumatol; 2020 Aug; 79(6):516-522. PubMed ID: 32399619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of giant cell arteritis - current approach and new possibilities.
    Videman J; Skácelová M; Horák P; Skoumalová A; Hraboš D
    Vnitr Lek; 2022; 68(5):266-272. PubMed ID: 36283815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtotal tongue necrosis in delayed diagnosed giant-cell arteritis: a case report.
    Biebl MO; Hugl B; Posch L; Tzankov A; Weber F; Perkmann R; Fraedrich G
    Am J Otolaryngol; 2004; 25(6):438-41. PubMed ID: 15547815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tocilizumab for treatment of large vessel vasculitis and polymyalgia rheumatica].
    Henes JC; Xenitidis T
    Z Rheumatol; 2013 Jun; 72(5):486-7. PubMed ID: 23615930
    [No Abstract]   [Full Text] [Related]  

  • 20. Giant cell arteritis--the methotrexate debate revisited.
    Rimar D; Rozenbaum M; Zisman D; Boulman N; Slobodin G; Eder L; Feld J; Rosner I
    J Rheumatol; 2006 Jul; 33(7):1458-9. PubMed ID: 16862661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.